PIEZO1 and breast carcinoma: Moreover, Piezo1 has been identified as a cancer-promoting factor in a variety of cancers, including hepatocellular carcinoma (Liu et al., 2021), gastric cancer (Wang et al., 2021), oral squamous cell carcinoma (Hasegawa et al., 2021), and breast cancer (Luo et al., 2022).